In this Friday’s PCT Grand Rounds, Dr. Gregory Marcus of the University of California, San Francisco, will present “n-of-1 Randomized Trials: CRAVE and I-STOP-AFib as Examples.” The Grand Rounds session will be held on Friday, May 6, at 1:00 pm eastern.
The CRAVE trial investigated the real-time effects of caffeine intake on atrial and ventricular ectopy. The I-STOP-AFib trial assessed the efficacy of trigger-based testing for atrial fibrillation on quality of life. Both studies used n-of-1 designs.